The BMJ retracts stem cell trial amid ongoing data integrity and reliability concerns

The BMJ retracts stem cell trial amid ongoing data integrity and reliability concerns The BMJ has retracted a clinical trial published on 29 October 2025: Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8). The decision follows an investigation by BMJ Group's content integrity team ...